FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310377219> ?p ?o ?g. }

• W4310377219 endingPage "307" @default.
• W4310377219 startingPage "299" @default.
• W4310377219 abstract "Objective To investigate the involvement of pretreatment C-reactive protein (CRP) and neutrophil-to-lymphocyte ratio (NLR) in the prognosis of patients who underwent intravesical bacillus Calmette-Guérin (BCG) therapy for non-muscle invasive bladder cancer (NMIBC). Methods The clinicopathological data of 1709 patients with NMIBC who underwent initial intravesical BCG therapy after transurethral resection of bladder tumor were retrospectively analyzed to evaluate the outcome of intravesical BCG therapy in a multicenter study conducted by the Japan Urological Oncology Group. The prognoses of these patients were analyzed to determine whether the biomarkers (CRP and NLR) could predict the efficacy of intravesical BCG therapy. Patients were divided into two groups according to the pretreatment CRP and NLR, with cutoff values defined as CRP ≥ 0.5 mg/dl and NLR ≥ 2.5, based on several previous reports. Results In the univariable analysis, CRP ≥ 0.5 mg/dl was significantly associated with intravesical recurrence, cancer-specific survival, and bladder cancer (BC) progression, while NLR ≥ 2.5 was not significantly associated with patient prognosis. In the multivariable analysis, CRP ≥ 0.5 mg/dl was significantly associated with intravesical recurrence and BC progression. The concordance index was used to examine the accuracy in predicting recurrence and progression events. While CRP was slightly, though not statistically significant, inferior to the European Association of Urology risk classification, the combination of them showed improved predictive accuracy. Conclusion This study suggests that CRP can be a prognostic factor after intravesical BCG therapy and may provide useful data for determining treatment and follow-up strategies for patients with NMIBC." @default.
• W4310377219 created "2022-12-10" @default.
• W4310377219 creator A5003368584 @default.
• W4310377219 creator A5007998286 @default.
• W4310377219 creator A5017624165 @default.
• W4310377219 creator A5020597801 @default.
• W4310377219 creator A5021578465 @default.
• W4310377219 creator A5036409458 @default.
• W4310377219 creator A5037097667 @default.
• W4310377219 creator A5037711521 @default.
• W4310377219 creator A5038206081 @default.
• W4310377219 creator A5047062255 @default.
• W4310377219 creator A5047716545 @default.
• W4310377219 creator A5049739469 @default.
• W4310377219 creator A5050544002 @default.
• W4310377219 creator A5062743790 @default.
• W4310377219 creator A5065031244 @default.
• W4310377219 creator A5067275958 @default.
• W4310377219 creator A5071455815 @default.
• W4310377219 creator A5073850979 @default.
• W4310377219 creator A5081087358 @default.
• W4310377219 creator A5089760587 @default.
• W4310377219 date "2022-11-30" @default.
• W4310377219 modified "2023-10-16" @default.
• W4310377219 title "C‐reactive protein as a prognostic predictor for non‐muscle invasive bladder cancer after intravesical bacillus Calmette‐Guérin therapy: A Japan Urological Oncology Group study analysis" @default.
• W4310377219 cites W1513594981 @default.
• W4310377219 cites W1532624029 @default.
• W4310377219 cites W1572827793 @default.
• W4310377219 cites W1890550626 @default.
• W4310377219 cites W1964897400 @default.
• W4310377219 cites W2002045993 @default.
• W4310377219 cites W2010447105 @default.
• W4310377219 cites W2014229457 @default.
• W4310377219 cites W2060913247 @default.
• W4310377219 cites W2162130153 @default.
• W4310377219 cites W2310639844 @default.
• W4310377219 cites W2519423603 @default.
• W4310377219 cites W2521826974 @default.
• W4310377219 cites W2576706490 @default.
• W4310377219 cites W2799408564 @default.
• W4310377219 cites W2893389698 @default.
• W4310377219 cites W2897790557 @default.
• W4310377219 cites W3012022092 @default.
• W4310377219 cites W3051680285 @default.
• W4310377219 cites W3120445389 @default.
• W4310377219 cites W3124793992 @default.
• W4310377219 cites W3128646645 @default.
• W4310377219 cites W3167773209 @default.
• W4310377219 cites W3171500593 @default.
• W4310377219 cites W3198719997 @default.
• W4310377219 cites W4243650202 @default.
• W4310377219 doi "https://doi.org/10.1111/iju.15106" @default.
• W4310377219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36448522" @default.
• W4310377219 hasPublicationYear "2022" @default.
• W4310377219 type Work @default.
• W4310377219 citedByCount "0" @default.
• W4310377219 crossrefType "journal-article" @default.
• W4310377219 hasAuthorship W4310377219A5003368584 @default.
• W4310377219 hasAuthorship W4310377219A5007998286 @default.
• W4310377219 hasAuthorship W4310377219A5017624165 @default.
• W4310377219 hasAuthorship W4310377219A5020597801 @default.
• W4310377219 hasAuthorship W4310377219A5021578465 @default.
• W4310377219 hasAuthorship W4310377219A5036409458 @default.
• W4310377219 hasAuthorship W4310377219A5037097667 @default.
• W4310377219 hasAuthorship W4310377219A5037711521 @default.
• W4310377219 hasAuthorship W4310377219A5038206081 @default.
• W4310377219 hasAuthorship W4310377219A5047062255 @default.
• W4310377219 hasAuthorship W4310377219A5047716545 @default.
• W4310377219 hasAuthorship W4310377219A5049739469 @default.
• W4310377219 hasAuthorship W4310377219A5050544002 @default.
• W4310377219 hasAuthorship W4310377219A5062743790 @default.
• W4310377219 hasAuthorship W4310377219A5065031244 @default.
• W4310377219 hasAuthorship W4310377219A5067275958 @default.
• W4310377219 hasAuthorship W4310377219A5071455815 @default.
• W4310377219 hasAuthorship W4310377219A5073850979 @default.
• W4310377219 hasAuthorship W4310377219A5081087358 @default.
• W4310377219 hasAuthorship W4310377219A5089760587 @default.
• W4310377219 hasConcept C121608353 @default.
• W4310377219 hasConcept C126322002 @default.
• W4310377219 hasConcept C126894567 @default.
• W4310377219 hasConcept C143998085 @default.
• W4310377219 hasConcept C2776914184 @default.
• W4310377219 hasConcept C2780352672 @default.
• W4310377219 hasConcept C2781195455 @default.
• W4310377219 hasConcept C71924100 @default.
• W4310377219 hasConcept C90924648 @default.
• W4310377219 hasConceptScore W4310377219C121608353 @default.
• W4310377219 hasConceptScore W4310377219C126322002 @default.
• W4310377219 hasConceptScore W4310377219C126894567 @default.
• W4310377219 hasConceptScore W4310377219C143998085 @default.
• W4310377219 hasConceptScore W4310377219C2776914184 @default.
• W4310377219 hasConceptScore W4310377219C2780352672 @default.
• W4310377219 hasConceptScore W4310377219C2781195455 @default.
• W4310377219 hasConceptScore W4310377219C71924100 @default.
• W4310377219 hasConceptScore W4310377219C90924648 @default.
• W4310377219 hasIssue "3" @default.
• W4310377219 hasLocation W43103772191 @default.
• W4310377219 hasLocation W43103772192 @default.

• next